ICYMI: View AACR 2020 Annual Meeting Sessions (April, June)
By: Julie Poucher Harbin, Senior Writer, DCI
The 2020 American Association of Cancer Research held its Virtual Annual Meeting April 27-28 (part 1) and June 22-24 (part 2).
Part 1 featured:
- An Opening Session: with messages from AACR president Elaine R. Mardis and Program Chair Antoni Ribas
- Clinical Plenary Sessions: more than 35 oral presentations along with perspectives on the science behind the clinical trials by expert discussants
- Clinical Trials Poster Sessions: brief video presentations of approximately 130 clinical trials (Poster videos will be available on demand beginning April 27 but will not be presented live.)
- Minisymposia showcasing basic and translational science
- A special minisymposium titled “Advancing Cancer Research Through an International Cancer Registry” will feature use cases of data available through AACR Project GENIE.
- Special Symposia: three special sessions on New Drugs on the Horizon that highlight first disclosures of innovative small molecules and biologics that have recently entered phase I clinical trials
- A Special Plenary on COVID-19 and Cancer
Among other content, this part of the virtual meeting featured about 200 Phase I, II, and III clinical trials as well as clinical trials in progress.
From Duke, postdoctoral researcher Hema Adhikari, PhD, presented a study that examined RAS-interacting proteins to determine how they may impact RAS-mediated oncogenesis. READ MORE ABOUT HER STUDY
The AACR Virtual Annual Meeting I sessions are now available to members for on-demand viewing through July 31.
*Only registered attendees may access the on-demand sessions. However, it's still possible to register for free to view these sessions. [Access information on membership].
Part 2 featured thousands of proffered papers in minisymposia and in an e-poster platform. This meeting also included an Opening Plenary Session with presentations on
This part of the virtual meeting included 20 award lectures from renowned scientists and patient advocates. More than 120 sessions were broadcast on 14 concurrent channels over three days, featuring 600 speakers, and more than 4,000 proffered papers presented in minisymposia and poster sessions.
The content focused on practice-changing clinical trials, innovative basic and translational research, and a comprehensive educational program. Highlights of the program included timely sessions on “COVID-19 and Cancer” as well as a session on “Racism and Racial Inequities in Cancer Research.”
From DCI, a presentation by urologic oncologist Daniel George, MD, was featured in the session: Under-representation in Clinical Trials and the Implications for Drug Development.